TMC Life Sciences Berhad
TMC Life Sciences Berhad, a prominent player in the biotechnology and healthcare sector, is headquartered in Malaysia. Founded in 1994, the company has established itself as a leader in providing innovative healthcare solutions, particularly in the fields of regenerative medicine and clinical research. With a strong operational presence across Southeast Asia, TMC Life Sciences focuses on advanced medical technologies and services that enhance patient care. The company offers a range of core products and services, including stem cell therapies and clinical trial management, distinguished by their commitment to quality and scientific excellence. TMC Life Sciences has achieved significant milestones, positioning itself as a trusted name in the industry, recognised for its contributions to medical advancements and patient outcomes.
DitchCarbon Score
How does TMC Life Sciences Berhad's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TMC Life Sciences Berhad's score of 33 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TMC Life Sciences Berhad's reported carbon emissions
In 2024, TMC Life Sciences Berhad reported total carbon emissions of approximately 12,506,000 kg CO2e, comprising 690,000 kg CO2e from Scope 1, 12,506,000 kg CO2e from Scope 2, and 12,910,000 kg CO2e from Scope 3 emissions. This reflects a significant increase in emissions compared to previous years, with Scope 1 emissions rising from 559,000 kg CO2e in 2023 and Scope 2 emissions increasing from 12,910,000 kg CO2e in 2023. In 2022, the company disclosed total emissions of about 8,000,000 kg CO2e from Scope 2 and 1,814,000 kg CO2e from Scope 3, indicating a trend of increasing emissions across all scopes. Notably, TMC Life Sciences has not set specific reduction targets or climate pledges, which may limit their ability to effectively manage and reduce their carbon footprint in line with industry standards. The company’s emissions data highlights the importance of addressing both direct and indirect emissions to achieve meaningful climate commitments. As TMC Life Sciences continues to grow, it will be crucial for them to implement strategies aimed at reducing their carbon emissions and enhancing sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 263,150 | 00,000 | 000,000 | 000,000 |
| Scope 2 | 14,390,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 0,000,000 | 0,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TMC Life Sciences Berhad is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
